跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-RANITIDINE TABLET 150 mg - HSA Drug Approval Details
Approvals
/
HSA
/
APO-RANITIDINE TABLET 150 mg
Approved
THERAPEUTIC
APO-RANITIDINE TABLET 150 mg
APOTEX INC
🇸🇬 Health Sciences Authority
Approval Date
Feb 18, 1991
Approval ID
a400e91af3cc8993
Company
APOTEX INC
Type
Therapeutic
Approval Details
Approval Id
a400e91af3cc8993
Drug Name
APO-RANITIDINE TABLET 150 mg
Product Name
APO-RANITIDINE TABLET 150 mg
Approval Number
SIN05429P
Approval Date
1991-02-18
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
A02BA02
Atc Item Name
ranitidine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
RANITIDINE HCl FORM II EQV RANITIDINE
150 mg
RANITIDINE HCL FORM II EQV RANITIDINE
150 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 18, 1991
Approval ID
a400e91af3cc8993
Type
Therapeutic
Back to HSA Approvals